A Multicenter Analysis of "Time to Microcatheter" for Endovascular Therapy in Acute Ischemic Stroke

Journal of Neuroimaging

Volumn 21, Issue 2, 2011, Pages 159-164

  Miley, Jefferson T ^a   Memon, Muhammad Zeeshan ^a   Hussein, Haitham M ^a   Valenta, Douglas A ^a   Suri, M Fareed K ^a   Vazquez, Gabriela ^a   Qureshi, Adnan I ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Acute ischemic stroke; Endovascular; Intraarterial thrombolysis; Stroke performance; Time to microcatheter

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BRAIN CIRCULATION; BRAIN ISCHEMIA; CARDIOVASCULAR PROCEDURES; CATHETERIZATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOVASCULAR SURGERY; FEMALE; HUMAN; IMAGING SYSTEM; INTUBATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; TIME SERIES ANALYSIS; TREATMENT DURATION;

AGED; ANALYSIS OF VARIANCE; CATHETERIZATION; CEREBRAL ANGIOGRAPHY; COMORBIDITY; CONTRAST MEDIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; PATIENT SELECTION; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79953065842     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2009.00432.x     Document Type: Article

References (32)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-774.
3. Tomsick T, Broderick J, Carrozella J, et al. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008;29:582-587.
4. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-1438.
5. Bose A, Henkes H, Alfke K, et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409-1413.
6. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177-1182.
7. Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000;283:3102-3109.
8. Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597-1616.
9. Qureshi AI, Alkawi A, Hussein HM, et al. Angiographic analysis of intravascular thrombus volume in patients with acute ischemic stroke. J Endovasc Ther 2007;14:475-482.
10. Burns TC, Rodriguez GJ, Patel S, et al. Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: a case-control study. AJNR Am J Neuroradiol 2008;29:1918-1924.
11. Qureshi AI, Janjua N, Kirmani JF, et al. Mechanical disruption of thrombus following intravenous tissue plasminogen activator for ischemic stroke. J Neuroimaging 2007;17:124-130.
12. Qureshi AI, Harris-Lane P, Kirmani JF, et al. Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study. Neurosurgery 2006;59:789-796; discussion 796-797.
13. Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:322-328.
14. Qureshi AI, Hussein HM, Abdelmoula M, et al. Subacute recanalization and reocclusion in patients with acute ischemic stroke following endovascular treatment. Neurocrit Care 2009;10(2):195-203.
15. Mayer SA, Copeland D, Bernardini GL, et al. Cost and outcome of mechanical ventilation for life-threatening stroke. Stroke 2000;31:2346-2353.
16. Santoli F, De Jonghe B, Hayon J, et al. Mechanical ventilation in patients with acute ischemic stroke: survival and outcome at one year. Intensive Care Med 2001;27:1141-1146.
17. Bushnell CD, Phillips-Bute BG, Laskowitz DT, et al. Survival and outcome after endotracheal intubation for acute stroke. Neurology 1999;52:1374-1381.
18. Saposnik G, Baibergenova A, Bayer N, et al. Weekends: a dangerous time for having a stroke? Stroke 2007;38:1211-1215.
19. De Silva DA, Ong SH, Elumbra D, et al. Timing of hospital presentation after acute cerebral infarction and patients' acceptance of intravenous thrombolysis. Ann Acad Med Singapore 2007;36:244-246.
20. Derex L, Adeleine P, Nighoghossian N, et al. Factors influencing early admission in a French stroke unit. Stroke 2002;33:153-159.
21. Maestroni A, Mandelli C, Manganaro D, et al. Factors influencing delay in presentation for acute stroke in an emergency department in Milan, Italy. Emerg Med J 2008;25:340-345.
22. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006;355:2308-2320.
23. Lee KY, Kim DI, Kim SH, et al. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:1470-1475.
24. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-1212.
25. Schaefer PW, Yoo AJ, Bell D, et al. CT angiography-source image hypoattenuation predicts clinical outcome in posterior circulation strokes treated with intra-arterial therapy. Stroke 2008;39:3107-3109.
26. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008;117:296-329.
27. Wolfe T, Suarez JI, Tarr RW, et al. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. J Stroke Cerebrovasc Dis 2008;17:121-128.
28. Poncyljusz W, Falkowski A, Kojder I, et al. Treatment of acute ischemic brain infarction with the assistance of local intraarterial thrombolysis with recombinant tissue-type plasminogen activator. Acta Radiol 2007;48:774-780.
29. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38:2633-2639.
30. Shaltoni HM, Albright KC, Gonzales NR, et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 2007;38:80-84.
31. Mattle HP, Arnold M, Georgiadis D, et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008;39:379-383.
32. Kim DJ, Kim DI, Byun JS, et al. Simple microwire and microcatheter mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients. Acta Radiol 2008;49:351-357.